Accelerated Aging testing is a process of putting packaged products into a chamber, elevating the test temperature to claim a specific expiration date for a medical device product or package. ASTM-F1980 is meant for sterile medical packaging but many companies and or organizations have been using it to claim specific expiration dates for their products.
Accelerated stability studies are used to calculate a product’s expiry date or life period rapidly when there is no real-time data available.
An accelerated ageing testing for medical devices is used to simulate real time shelf-life ageing, in order to validate shelf-life claims. This process is carried out according to guidelines given in ASTM F1980 – Standard Guide for Accelerated Ageing of Sterile Medical Device Packages.
Aspect | Accelerated Aging | Real-Time Aging |
Purpose | Predict long-term product stability in a shorter time | Confirm product stability over actual shelf life |
Testing Conditions | Elevated temperature and sometimes humidity | Standard storage conditions (e.g., room temperature, ambient humidity) |
Timeframe | Shortened (e.g., weeks to months) | Full product shelf life (e.g., 1–5 years) |
Basis | Arrhenius equation (temperature accelerates chemical reactions) | Required for long-term validation and regulatory support |
Regulatory Acceptance | Accepted for initial shelf-life claims (with proper justification) | Required for long-term validation and regulatory support |
Cost and Resources | Lower long-term cost; faster results | Higher cost due to long duration and storage needs |
Reliability | Predictive but dependent on assumptions and proper modeling | Highly reliable as it reflects actual product behavior |
Standard Guidance | Follows ASTM F1980 and similar standards | Based on internal protocols and long-term observation |
Common Practice | Used for rapid market entry and packaging validation | Conducted in parallel to confirm accelerated aging data |
Both methods are essential: accelerated aging provides fast, predictive data, while real-time aging ensures long-term product safety and compliance.
Accelerated aging testing is a valuable process for medical device manufacturers aiming to predict a product’s shelf life without waiting years for real-time results. This method simulates long-term storage conditions by exposing products to elevated temperatures, helping estimate how packaging and materials will hold up over time. One of the primary benefits is faster market entry, as the Accelerated Aging test method allows companies to justify shelf-life claims early in development. It also helps identify packaging or material issues before full-scale production, supporting better product design and compliance with standards like ASTM F1980 and ISO 11607.
For medical devices, this testing ensures product stability, particularly for sterile devices where packaging integrity is critical. While real-time aging is still necessary for regulatory validation, accelerated aging offers predictive insights that help manufacturers make timely, informed decisions.
Primarily medical device manufacturers will use accelerated aging testing in their package validation to be in compliance with ISO 11607.
ASTM-F1980 is the document; the theory itself is the Q10 theory. For every 10 degree increase it doubles the reaction rate of the materials. This Q10 factor came from the food industry. This is not an exact science but the FDA allows you to use this theory to get your products to market faster. But you will need to follow it up with real time aging. In doing so, you want to have conclusive evidence that you are not going to have issues with your package or product for that specific shelf life.
For calculation of shelf life of medical device by conducting accelerated aging testing shelf life study.
[TAA-TRT/10]
Where TAA = Accelerated aging temperature
TRT = Ambient temperature.
You need to understand where the softening or melting point is before you can pick a test temperature that is going to work properly. Accelerated aging is meant for homogeneous materials while medical devices are comprised of multiple materials can lead to trouble.
Validation studies for ISO 11607 compliance should also cover packaging processes including sterile barrier system forming and sealing.
Accelerated aging is crucial in the medical device industry as it allows manufacturers to predict a product’s shelf life and stability in a much shorter timeframe. By exposing the device to elevated temperatures and environmental stress, accelerated aging simulates the effects of time, helping determine how the product will perform over its intended shelf life. This is especially important for sterile or degradable products where material integrity and packaging must be maintained to ensure patient safety. Accelerated aging supports faster regulatory submissions and market entry by providing early data on product durability and performance. It is commonly used during product development and prior to product launch, enabling manufacturers to make timely decisions about packaging, labeling, and expiration dating. Although real-time aging is eventually required for final validation, accelerated aging offers a valuable, predictive tool that helps ensure quality and compliance while reducing time to market.
Annexes IX to XI of (EU) 2017/745 Medical Devices Regulation (MDR)
For more detail on the information contact us.
Shelf life is calculated using ASTM F1980, a standard guide designed specifically for accelerated aging testing of sterile medical device packaging. This method simulates the long-term effects of time by subjecting products to elevated temperatures, allowing manufacturers to predict product stability faster than real-time studies.
The calculation uses the Arrhenius equation and a Q10 factor (typically 2), based on the principle that a 10°C increase in temperature doubles the chemical reaction rate. The formula used is:
Shelf Life = Accelerated Aging Time × 2^[(TAA – TRT)/10]
Where TAA is the accelerated aging temperature and TRT is the ambient room temperature.
This Accelerated Aging test method is widely accepted for establishing preliminary shelf life claims, especially when real-time data isn’t yet available. While accelerated aging medical devices testing speeds up market readiness, it should be followed by real-time aging to ensure regulatory compliance and long-term product performance.
Yes, accelerated aging data is accepted by the FDA—provided it follows recognized standards and is properly justified. The FDA accepts accelerated aging testing as a predictive tool to support initial shelf-life claims of medical devices, particularly when real-time data is not yet available. This process is typically conducted using the Accelerated Aging test method outlined in ASTM F1980, which simulates long-term aging through elevated temperature conditions. While it offers a faster route to market, manufacturers are expected to conduct real-time aging studies in parallel to confirm long-term stability. For sterile or sensitive products, accelerated aging medical devices testing is critical for regulatory submissions and packaging validation. As part of a comprehensive validation approach, especially under ISO 11607, accelerated aging testing helps demonstrate that the device will maintain safety and performance over its intended shelf life. However, it’s essential to ensure the materials and packaging systems tested can withstand the chosen accelerated conditions without degradation or compromise.
Using incorrect temperatures during accelerated aging testing can lead to inaccurate predictions of a medical device’s shelf life and overall performance. If the temperature is too high, it may cause material degradation or melting, which wouldn’t occur under normal storage conditions. Conversely, using temperatures that are too low may not sufficiently accelerate the aging process, leading to unreliable or inconclusive data. This can result in false assumptions about the durability or sterility of the device packaging. In regulated environments, especially for accelerated aging medical devices, such missteps can delay product approvals and raise compliance issues. Since the Accelerated Aging test method relies on principles like the Arrhenius equation and Q10 factor, selecting the wrong temperature undermines the scientific validity of the results. It’s essential to understand material limits and follow standardized procedures like ASTM F1980 to minimize risk and ensure meaningful outcomes. When done properly, accelerated aging testing provides fast, predictive insights—but only when temperature settings are accurately defined and validated.
The standard widely followed for accelerated aging testing in the medical device industry is ASTM F1980. This guideline, known as Standard Guide for Accelerated Aging of Sterile Barrier Systems for Medical Devices, outlines the recommended process for simulating real-time aging using elevated temperatures. The purpose of this standard is to help predict the shelf life and long-term stability of medical device packaging in a compressed time frame.
Accelerated aging medical devices testing is crucial when real-time data is unavailable and quick validation is required to meet market demands. By applying the Accelerated Aging test method, manufacturers use the Arrhenius equation to determine aging duration based on specific temperatures. This method is essential for validating packaging integrity and product durability, especially for sterile medical devices.
While accelerated aging testing is predictive, it must be followed up with real-time studies for final regulatory approval. It plays a key role in faster regulatory submission, market readiness, and ISO 11607 compliance.
Recent Post
How to Manage EU IVDR Compliance Challenges Effectively
Are You Looking For Medical Devices Certifications?
Contact Us